Safety and Immunogenicity of Human Serum Albumin-Free MMR Vaccine in US Children Aged 12-15 Months.

MLA

Mufson, Maurice A., et al. “Safety and Immunogenicity of Human Serum Albumin-Free MMR Vaccine in US Children Aged 12-15 Months.” Journal of the Pediatric Infectious Diseases Society, vol. 4, no. 4, Dec. 2015, pp. 339–48. EBSCOhost, https://doi.org/10.1093/jpids/piu081.

APA

Mufson, M. A., Diaz, C., Leonardi, M., Harrison, C. J., Grogg, S., Carbayo, A., Carlo-Torres, S., JeanFreau, R., Quintero-Del-Rio, A., Bautista, G., Povey, M., Da Costa, C., Nicholson, O., & Innis, B. L. (2015). Safety and Immunogenicity of Human Serum Albumin-Free MMR Vaccine in US Children Aged 12-15 Months. Journal of the Pediatric Infectious Diseases Society, 4(4), 339–348. https://doi.org/10.1093/jpids/piu081

Chicago

Mufson, Maurice A, Clemente Diaz, Michael Leonardi, Christopher J Harrison, Stanley Grogg, Antonio Carbayo, Simon Carlo-Torres, et al. 2015. “Safety and Immunogenicity of Human Serum Albumin-Free MMR Vaccine in US Children Aged 12-15 Months.” Journal of the Pediatric Infectious Diseases Society 4 (4): 339–48. doi:10.1093/jpids/piu081.